Chromatography
Peptide Sample Analysis Using EternityXT
Mar 16 2018
The peptide therapeutic market continues to develop fast where pharmaceutical companies focus in these types of compounds for large number of diseases. Chromatography plays an important role across the entire drug development cycle. Kromasil EternityXT, chemically stable merged inorganic/organic silica material for reversed phase chromatography, is a perfect material to be used from analysis to scale up of peptides.
With excellent mechanical and chemical stability, the Kromasil EternityXT materials offer first-rate separation power as well as loadability at low, medium and high pH. EternityXT columns are provided in 1.8 µm particles for UHPLC, 2.5 µm particles for both UHPLC and HPLC applications and finally 5 µm particles for HPLC and semipreparative chromatography. The C18 and C8 chemistries are also available in bulk for purification. The Kromasil EternityXT columns are based on patented technology, resulting from 30 years of expertise and used by chromatographers worldwide.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan